Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate β-amyloid neurotoxicity

被引:21
作者
Liu, Qiang [1 ]
Wu, Jie [1 ]
机构
[1] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA
关键词
nicotinic acetylcholine receptor; beta-amyloid peptides; neurodegeneration; Alzheimer's disease;
D O I
10.1111/j.1745-7254.2006.00430.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Alzheimer's disease (AD) is the most common form of brain dementia characterized by the accumulation of beta-amyloid peptides (A beta) and loss of forebrain cholinergic neurons. A beta accumulation and aggregation are thought to contribute to cholinergic neuronal degeneration, in turn causing learning and memory deficits, but the specific targets that mediate A beta neurotoxicity remain elusive. Recently, accumulating lines of evidence have demonstrated that A beta directly modulates the function of neuronal nicotinic acetylcholine receptors (nAChRs), which leads to the new hypothesis that neuronal nAChRs may serve as important targets that mediate A beta neurotoxicity. In this review, we summarize current studies performed in our laboratory and in others to address the question of how A beta modulates neuronal nAChRs, especially nAChR subunit function.
引用
收藏
页码:1277 / 1286
页数:10
相关论文
共 115 条
[1]  
Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117
[2]   α7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus [J].
Alkondon, M ;
Braga, MFM ;
Pereira, EFR ;
Maelicke, A ;
Albuquerque, EX .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :59-67
[3]  
Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396
[4]  
Alkondon M, 1996, J PHARMACOL EXP THER, V279, P1491
[5]  
ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455
[6]   Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes [J].
Anguiano, M ;
Nowak, RJ ;
Lansbury, PT .
BIOCHEMISTRY, 2002, 41 (38) :11338-11343
[7]  
ARISPE N, 1994, ANN NY ACAD SCI, V747, P256
[8]   COMPARATIVE ALTERATIONS OF NICOTINIC AND MUSCARINIC BINDING-SITES IN ALZHEIMERS AND PARKINSONS DISEASES [J].
AUBERT, I ;
ARAUJO, DM ;
CECYRE, D ;
ROBITAILLE, Y ;
GAUTHIER, S ;
QUIRION, R .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) :529-541
[9]   Alzheimer's disease and the basal forebrain cholinergic system:: relations to β-amyloid peptides, cognition, and treatment strategies [J].
Auld, DS ;
Kornecook, TJ ;
Bastianetto, S ;
Quirion, R .
PROGRESS IN NEUROBIOLOGY, 2002, 68 (03) :209-245
[10]  
Avdulov NA, 1997, J NEUROCHEM, V68, P2086